News Medical: Researchers examine risk of four common types of ovarian cancer in women with different childbearing patterns The more children a woman has or whether a woman has had her fallopian tubes cut lowers the risk of different types of ovarian cancer to different levels, according to new research presented at the ... Researchers examine risk of four common types of ovarian cancer in women with different childbearing patterns The Guardian: Repurposed drug may extend survival in aggressive ovarian cancer, trial shows The Mirror: Ovarian cancer breakthrough as patients who take pill 'less likely to die' A drug for a rare disease may extend the lives of ovarian cancer patients, a new trial has suggested. Patients with a certain type of ovarian cancer may also benefit by taking a drug for Cushing’s ...
Ovarian cancer breakthrough as patients who take pill 'less likely to die' AOL: Drug for rare disease could be used to extend lives of ovarian cancer patients, study finds A drug typically used for a rare disorder could extend the lives of patients battling a form of ovarian cancer, a study has found. Women diagnosed with platinum-resistant ovarian cancer, a type where ... Drug for rare disease could be used to extend lives of ovarian cancer patients, study finds SurvivorNet on MSN: Newly approved ovarian cancer treatment combination with the drug Lifyorli helps give time after relapse The FDA has approved Lifyorli (relacorilant) plus Abraxane for certain platinum‑resistant ovarian cancer patients, offering a new option after prior treatments stop working. Newly approved ovarian cancer treatment combination with the drug Lifyorli helps give time after relapse Women with a certain type of ovarian cancer may benefit from taking a drug used to treat a rare disease, a new study has found ...
ovarian cancer types, MarketWatch: Zentalis Pharmaceuticals Climbs on Selection of Higher Dose for Ovarian-Cancer Trials Shares of Zentalis Pharmaceuticals rose after the company selected a higher dose of azenosertib to treat ovarian cancer in two clinical trials. The stock gained 49%, to $4.12, Thursday afternoon after ... FDA fast tracked ZW191 for platinum-resistant ovarian cancer, aiming to speed development of a potential new option for patients with limited treatments. The U.S. Food and Drug Administration (FDA) ...
ovarian cancer types, A newly identified interaction between ovarian cancer cells and surrounding abdominal cells helps explain the cancer’s unusually fast and aggressive spread.
